학술논문

Effects of Inhaled Corticosteroid/Long-Acting β2-Agonist Combination on the Airway Microbiome of Patients with Chronic Obstructive Pulmonary Disease: A Randomized Controlled Clinical Trial (DISARM).
Document Type
journal article
Source
American Journal of Respiratory & Critical Care Medicine; 11/15/2021, Vol. 204 Issue 10, p1143-1152, 45p
Subject
CORTICOSTEROIDS
OBSTRUCTIVE lung disease treatment
RANDOMIZED controlled trials
COMBINATION drug therapy
BRONCHOSCOPY
FORMOTEROL
ADRENERGIC beta agonists
RESEARCH
ADRENOCORTICAL hormones
RESEARCH methodology
CELL receptors
MEDICAL cooperation
EVALUATION research
TREATMENT effectiveness
COMPARATIVE studies
OBSTRUCTIVE lung diseases
RESEARCH funding
INHALATION administration
STATISTICAL sampling
Language
ISSN
1073449X
Abstract
Copyright of American Journal of Respiratory & Critical Care Medicine is the property of American Thoracic Society and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)